Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis

Acta Tropica
J K ThuitaR Brun

Abstract

The choice of drugs for the treatment of sleeping sickness is extremely limited. To redress this situation, the recently synthesised diamidine, 2,5-bis(4-amidinophenyl)-furan (DB75, furamidine) and its methamidoxime prodrug, 2,5-bis(4-amidinophenyl)-furan-bis-O-methylamidoxime (DB289, pafuramidine) were, together with pentamidine, evaluated for efficacy in acute rodent models. The activity was compared in three common mouse models that mimic the first stage of human African trypanosomiasis. The mice were infected with the pleomorphic T .b. rhodesiense strains KETRI2537 and STIB900 or with the monomorphic T. b. brucei strain STIB795. Importantly, DB75 showed activity superior to that of pentamidine at comparable doses in all three mouse models. Complete cures were achieved with oral dosing of the prodrug DB289 in all three models without any overt toxicity. This shows that the prodrug strategy was successful in terms of reducing toxicity and increasing efficacy and oral bioavailability.

References

Jan 1, 1990·Annals of the New York Academy of Sciences·R R TidwellJ E Hall
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·M G EtchegorryD Legros

❮ Previous
Next ❯

Citations

Sep 10, 2013·Bioorganic & Medicinal Chemistry·Laixing HuDavid W Boykin
Nov 26, 2009·Journal of Medicinal Chemistry·Stanislav A BakunovRichard R Tidwell
Sep 4, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Alison H HarrillPaul B Watkins
Jul 1, 2009·Antimicrobial Agents and Chemotherapy·Christophe DardonvilleReto Brun
May 12, 2010·Antimicrobial Agents and Chemotherapy·Denise da Gama Jaén BatistaMaria de Nazaré Correia Soeiro
Mar 18, 2009·Antimicrobial Agents and Chemotherapy·Robert H BarkerEdmund Sybertz
Aug 5, 2011·PloS One·Denise da Gama Jaén BatistaMaria de Nazaré Correia Soeiro
Aug 18, 2010·Marine Drugs·Fernando ScalaDeniz Tasdemir
Aug 13, 2014·Drug Design, Development and Therapy·Warda A HussinWael M El-Sayed
Sep 29, 2015·Expert Review of Anti-infective Therapy·Amy J Jones, Vicky M Avery
Dec 3, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·José L AriasJosé A García-Salcedo
Apr 27, 2011·Phytotherapy Research : PTR·Sevda Süzgeç-SelçukDeniz Tasdemir
Jan 16, 2010·Phytotherapy Research : PTR·Andrea AllmendingerDeniz Tasdemir
Jun 26, 2013·Journal of Medicinal Chemistry·Donald A PatrickRichard R Tidwell
Jun 26, 2015·PLoS Pathogens·Juan D Unciti-BrocetaJosé A Garcia-Salcedo
Oct 7, 2009·Nature Reviews. Microbiology·Mark C Field, Mark Carrington
May 24, 2019·PLoS Neglected Tropical Diseases·Paula MacGregorMark Carrington
Jul 7, 2018·Beilstein Journal of Organic Chemistry·Sayantan BhaduriDev P Arya
Aug 13, 2011·ChemMedChem·Victoria C SmithPaul G Wyatt
Jul 15, 2020·Nature Microbiology·Manuel SaldiviaSrinivasa P S Rao
Feb 26, 2020·Tropical Medicine and Infectious Disease·Emily A DickieMichael P Barrett
Mar 10, 2009·Journal of Medicinal Chemistry·Svetlana M BakunovaRichard R Tidwell
Jul 18, 2009·Journal of Medicinal Chemistry·Svetlana M BakunovaRichard R Tidwell
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Violeta KourbeliIoannis P Papanastasiou
Jul 10, 2010·Journal of Natural Products·Erik L RegaladoOlivier P Thomas
Mar 7, 2018·ACS Chemical Neuroscience·Frank MatthesSybille Krauss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.